Received Jan 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | Z011972 | OT |
no additional AE; late shipment; Caller reports VAQTA that experienced a late shipment was told by shipper Sanofi product was not viable and marked "do not use". Product was administered to 3 patients. Because this was a late shipment, storage and temperature conditions were unknown; This spontaneous report was received from an administrator and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies, drug reactions or allergies were not reported. On 04-Dec-2025, the patient was vaccinated with a dose of Hepatitis A Vaccine, Inactivated (VAQTA) (lot # Z011972, confirmed as valid, expiration date: 13-Oct-2026) (strength, route of administration, anatomical location not provided) as Prophylaxis, which was reported as not viable and marked as "do not use" (poor quality vaccine administered). Because it was a late shipment, storage and temperature conditions were unknown. No additional adverse events reported. This is one of 3 cases reported by the same reporter.